Hatch-Waxman goes to Taiwan

Published date16 April 2018
Law FirmSterne, Kessler, Goldstein & Fox P.L.L.C.
AuthorMiklos Gaszner, Ph.D.,Paul Calvo, Ph.D.
Subject MatterFDA,Patents,Hatch-Waxman,Biobased Chemicals,Prescription Drugs,Generic Drugs,Foreign Patent Applications,Biologics,Patent Applications,Pharmaceutical Patents,Taiwan,Pharmaceutical Industry,Marketing Exclusivity Periods

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT